EirGenix Revenue

EirGenix had revenue of 248.22M TWD in the quarter ending September 30, 2024, with 17.39% growth. This brings the company's revenue in the last twelve months to 1.17B, up 18.58% year-over-year. In the year 2023, EirGenix had annual revenue of 1.02B, down -30.95%.

Revenue (ttm)

1.17B

Revenue Growth

+18.58%

P/S Ratio

21.22

Revenue / Employee

n/a

Employees

n/a

Market Cap

24.87B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.02B	-458.36M	-30.95%
Dec 31, 2022	1.48B	-216.34M	-12.75%
Dec 31, 2021	1.70B	625.52M	58.36%
Dec 31, 2020	1.07B	595.75M	125.14%
Dec 31, 2019	476.09M	193.88M	68.70%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	8.32B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	16.71B
Lotus Pharmaceutical	17.59B
Lumosa Therapeutics	37.82M
Oneness Biotech	112.20M
Polaris Group	75.65M
Pegavision	7.06B

Revenue Rankings